Sequenom, Inc.

This study enrolls pregnant women between 11-14 weeks of pregnancy to collect blood samples and pregnancy outcome data. The goal is to see how well a new blood test (Labcorp Preeclampsia Screen) can predict early and preterm preeclampsia. About 6,550 women will participate, and r…

This study is testing a blood test called Proclarix to see if it can better predict which men have aggressive prostate cancer. About 500 men scheduled for a prostate biopsy will give a blood sample before the procedure. The test results will be compared to the biopsy results to s…